Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.86 USD
Change Today -0.03 / -1.59%
Volume 58.1K
PTIE On Other Exchanges
PTIE is not on other exchanges.
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nadav Friedmann Ph.D., M.D.

Chief Operating Officer, Chief Medical Officer and Director, Pain Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Nadav Friedmann, Ph.D., M.D., has been the Chief Operating Officer and Chief Medical Officer of Pain Therapeutics Inc. since October 2001 and July 2004 respectively. Dr. Friedmann is an Owner of EMET Research Inc and serves as its President. He served as the President and Chief Executive Officer of Daiichi Pharmaceutical Corporation from 1997 to April 2000 and Consultant to the Board of Directors of Daiichi Pharmaceutical Co., Ltd. from 1995 to 1997. From 1992 to ...

Read Full Background

Corporate Headquarters*

7801 North Capital of Texas Highway
Austin, Texas 78731

United States

Phone: 512-501-2444
Fax: 512-614-0414

Board Members Memberships*

Chief Operating Officer, Chief Medical Officer and Director


University of California - San Diego
Albert Einstein College of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$283,500

Stock Options*

All Other Compensation$9,270
Exercised Options257,388
Exercised Options Value$276,107
Exercisable Options2,912,732
Unexercisable Options841,803
Total Value of Options$276,107
Total Number of Options4,011,923

Total Compensation*

Total Annual Cash Compensation$292,770
Total Short Term Compensation$283,500
Other Long Term Compensation$9,270
Total Calculated Compensation$897,583
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTIE:US $1.86 USD -0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at